Huiqing Wu

Title: Huiqing Wu: Innovator in Cancer Research

Introduction

Huiqing Wu is a notable inventor based in San Marino, CA (US). He has made significant contributions to the field of cancer research, particularly in the area of miRNA expression signatures for predicting cancer metastasis and prognosis. With a total of 2 patents, his work is paving the way for advancements in cancer diagnostics and treatment.

Latest Patents

Huiqing Wu's latest patents include a groundbreaking invention titled "4-miRNA signature for predicting clear cell renal cell carcinoma metastasis and prognosis." This patent provides an miRNA expression signature comprising a set of one or more miRNAs associated with metastatic cancer. In one embodiment, the expression signature is selected from the group consisting of miR-10b, miR-139-5p, miR-130b, and miR-199b-5p. Notably, miR-199b-5p and miR-130b are overexpressed in metastatic cancer, while miR-10b and miR-139-5p are downregulated. This expression signature can be utilized in methods for predicting metastasis, assessing the risk of developing metastasis, or determining prognosis in cancer patients.

Career Highlights

Huiqing Wu is affiliated with the Beckman Research Institute, City of Hope, where he continues to engage in innovative research. His work is characterized by a commitment to improving cancer treatment outcomes through scientific discovery and technological advancement.

Collaborations

Huiqing Wu collaborates with Xiwei Wu, a fellow researcher who contributes to their shared goals in cancer research. Their partnership exemplifies the collaborative spirit that drives innovation in the scientific community.

Conclusion

Huiqing Wu's contributions to cancer research through his patents and collaborations highlight the importance of innovation in the medical field. His work is instrumental in advancing our understanding of cancer metastasis and improving patient prognoses.